Neuroglobin (Ngb) is an endogenous neuroprotective molecule against hypoxic/ischemic brain injury, but the underlying mechanisms remain largely undefined. Our recent study revealed that Ngb can bind to voltagedependent anion channel (VDAC), a regulator of mitochondria permeability transition (MPT). In this study we examined the role of Ngb in MPT pore (mPTP) opening following oxygen-glucose deprivation (OGD) in primary cultured mouse cortical neurons. Co-immunoprecipitation (Co-IP) and immunocytochemistry showed that the binding between Ngb and VDAC was increased after OGD compared to normoxia, indicating the OGD-enhanced Ngb-VDAC interaction. Ngb overexpression protected primary mouse cortical neurons from OGD-induced neuronal death, to an extent comparable to mPTP opening inhibitor, cyclosporine A (CsA) pretreatment. We further measured the role of Ngb in OGD-induced mPTP opening using Ngb overexpression and knockdown approaches in primary cultured neurons, and recombinant Ngb exposure to isolated mitochondria. Same as CsA pretreatment, Ngb overexpression significantly reduced OGD-induced mPTP opening markers including mitochondria swelling, mitochondrial NAD + release, and cytochrome c (Cyt c) release in primary cultured neurons. Recombinant Ngb incubation significantly reduced OGD-induced NAD + release and Cyt c release from isolated mitochondria. In contrast, Ngb knockdown significantly increased OGD-induced neuron death, and increased OGD-induced mitochondrial NAD + release and Cyt c release as well, and these outcomes could be rescued by CsA pretreatment. In summary, our results demonstrated that Ngb overexpression can inhibit OGD-induced mPTP opening in primary cultured mouse cortical neurons, which may be one of the molecular mechanisms of Ngb's neuroprotection.
Introduction
Neuroglobin (Ngb) is an oxygen binding globin protein that is highly expressed in brain neurons (Wystub et al., 2003) . Since its discovery in 2000, a large volume of evidence has proven that Ngb is an endogenous protective molecule for neurons against hypoxic/ischemic insults both in vitro and in vivo (Burmester and Hankeln, 2009; Greenberg et al., 2008; Yu et al., 2009a) . A more recent study showed that Ngb was upregulated in the peri-infarct area of ischemic human brain tissues, suggesting the clinical relevance of Ngb (Jin et al., 2010) . Moreover, emerging evidence has demonstrated that Ngb may have broad translational implications in other neurological disorders. For instance, Ngb overexpression was also found to be protective against beta-amyloidinduced neurotoxicity and Alzheimer's phenotype in mice (Khan et al., 2007) and glaucomatous retinal ganglion cell damage (Wei et al., 2011) .
Given the neuroprotective effect of Ngb, strategies to develop Ngbtargeted therapeutics against stroke and related neurological disorders have been proposed (Greenberg et al., 2008; Yu et al., 2012a) . However, the molecular mechanisms of Ngb neuroprotection remain poorly understood. Previous reports suggested that Ngb may play a role in scavenging reactive oxygen species (ROS) (Fordel et al., 2007) and modulating nitric oxide homeostasis (Brunori et al., 2005) , and that Ngb may serve as a hypoxia sensor (Wakasugi and Morishima, 2005) in neurons. Furthermore, Ngb was found to be closely related to mitochondria (Schmidt et al., 2003) . Our lab has demonstrated that Ngb overexpression preserves mitochondrial function, including ATP production and mitochondria membrane potential in primary cultured neurons after hypoxia (Liu et al., 2009) . These findings suggest an important role of mitochondria in Ngb neuroprotection. E-mail addresses: zyu@partners.org (Z. Yu), wangxi@helix.mgh.harvard.edu (X. Wang).
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